PAPD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.99360536359927E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29779999968882E-07 |
Normal-vs-Stage2 |
8.35319999999973E-05 |
Normal-vs-Stage3 |
2.76179079605754E-12 |
Normal-vs-Stage4 |
2.97595281750773E-12 |
Stage1-vs-Stage2 |
4.394600E-01 |
Stage1-vs-Stage3 |
2.255200E-03 |
Stage1-vs-Stage4 |
6.211300E-04 |
Stage2-vs-Stage3 |
2.662400E-01 |
Stage2-vs-Stage4 |
1.367370E-01 |
Stage3-vs-Stage4 |
5.405600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.0094040854608E-11 |
Normal-vs-AfricanAmerican |
6.65030031044012E-10 |
Normal-vs-Asian |
9.830600E-01 |
Caucasian-vs-AfricanAmerican |
1.240240E-01 |
Caucasian-vs-Asian |
3.272400E-02 |
AfricanAmerican-vs-Asian |
3.817700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.14620543559363E-11 |
Normal-vs-Female |
5.96700000521366E-08 |
Male-vs-Female |
1.412370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.51442999999363E-05 |
Normal-vs-Age(41-60Yrs) |
2.38699999766112E-08 |
Normal-vs-Age(61-80Yrs) |
7.84217135674226E-12 |
Normal-vs-Age(81-100Yrs) |
2.337000E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.083600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.856200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.984000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.930300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.479200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.976400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.948300E-02 |
Normal-vs-Grade 2 |
9.56750000002948E-07 |
Normal-vs-Grade 3 |
1.50419676714364E-11 |
Normal-vs-Grade 4 |
1.6251444634463E-12 |
Grade 1-vs-Grade 2 |
5.918600E-01 |
Grade 1-vs-Grade 3 |
1.036370E-01 |
Grade 1-vs-Grade 4 |
1.604160E-03 |
Grade 2-vs-Grade 3 |
1.116490E-02 |
Grade 2-vs-Grade 4 |
3.8834000004595E-07 |
Grade 3-vs-Grade 4 |
2.677800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.101770E-03 |
Normal-vs-ccB subtype |
1.7430501486615E-12 |
ccA subtype-vs-ccB subtype |
8.34159999962836E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.79139991308386E-10 |
Normal-vs-N1 |
3.57560000000534E-05 |
N0-vs-N1 |
3.918000E-01 |
|
|